Navigation Links
CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
Date:6/4/2008

VIENNA, Va., June 4 /PRNewswire-FirstCall/ -- In response to numerous shareholder questions, CEL-SCI CORPORATION (Amex: CVM) is providing an update on the construction of its manufacturing facility near Baltimore, Maryland. The facility, when fully built out, will comprise 73,000 square feet and will be used to manufacture Multikine(R), the Company's lead cancer product. This dedicated facility will produce the Multikine that will be used for CEL-SCI's pivotal Phase III clinical trial for first-line therapy of previously untreated head and neck cancer patients, and subsequently for sale following approval of the drug.

Upon completion of the first phase of the build out (28,000 square feet) in the 2008 third quarter, the facility will be capable of supporting approximately $600 million of annual commercial sales of Multikine. The facility build out is currently about 70% complete. The facility is being developed for CEL-SCI by BioRealty, Inc. (http://www.biorealty.com) and the design builder is BE&K, Inc. (http://www.bek.com/index.asp). Pictures of the manufacturing facility, located close to Baltimore, MD, can be accessed on CEL-SCI's website at http://www.cel-sci.com under "Special Highlights", "Pictures of Manufacturing Facility".

"CEL-SCI has been advised by BE&K that the manufacturing facility is on target to be completed on schedule," said Geert Kersten, CEL-SCI's Chief Executive Officer. "The facility will provide CEL-SCI with tight control over the Multikine manufacturing process, eliminating key risks to the successful completion of the pivotal Phase III trial
'/>"/>

SOURCE CEL-SCI CORPORATION
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. CEL-SCI to Present at the Noble Financial Conference
2. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
5. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
6. BioElectronics Corporation Announces Singapore and Malaysia Sales
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
9. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
10. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
11. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... As one of the 10 largest medical ... & Clinical Lab Expo is the place where breakthrough ... to the healthcare world. This year, many of the ... include the latest diagnostic technology in the field of ... biosensors have enabled the development of "labs-on-a-chip" that can ...
(Date:8/1/2014)... Research and Markets has announced the addition ... and Analysis Market 2014-2018" report to their offering. ... Single Nucleotide Polymorphism (SNP) genotyping is the screening and ... of various species. SNPs are commonly present in all ... analyze thousands of SNPs and has the potential for ...
(Date:8/1/2014)... Testing the mechanical properties of ... understanding embryonic development. How and why embryonic ... functionally distinct tissues is important because abnormalities can ... McDevitt, Melissa Kinney, and Rabbia Saeed worked from ... cues to control many aspects of embryo development. ...
(Date:7/31/2014)... a good reason people over 60 are not donor ... and weakens with time, making the elderly prone to ... Francisco research team now has discovered a reason why. ... the inability of blood-forming cells to maintain blood production ... molecular defects that could be restored for rejuvenation therapies," ...
Breaking Biology Technology:Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 2Lab-on-a-Chip Technology to Be Featured at 2014 AACC Annual Meeting & Clinical Lab Expo 3Global Single Nucleotide Polymorphism (SNP) Genotyping and Analysis Market 2014-2018 2Study Links Biomechanics and Gene Expression in Stem Cells 2Key to aging immune system is discovered 2
... Calif., Oct. 15 ... INKN ), an innovative nanotechnology company developing ... industry, medical diagnostics and sensors and biotechnology research ... its first product offering – the StemDisc450™, a ...
... NORWALK, Conn., Oct. 15 UBM Medica today announces ... ) from MediSpecialty.com, Inc.   OBGYN.net is ... and patients.  The site provides article-based and multimedia content ... online forums – some of which have been running ...
... CoreLab Partners, Inc , the global entity resulting ... in February of this year, has launched a full ... as it relates to Dual Energy X-Ray Absorptiometry ( ... that we have formally launched state-of-the-art imaging solutions to ...
Cached Biology Technology:Shrink Nanotechnologies Unveils Product Image of Initial StemDisc450 Prototype 2Shrink Nanotechnologies Unveils Product Image of Initial StemDisc450 Prototype 3Shrink Nanotechnologies Unveils Product Image of Initial StemDisc450 Prototype 4UBM Medica Acquires Leading Online Community OBGYN.net 2UBM Medica Acquires Leading Online Community OBGYN.net 3CoreLab Partners Launches New DXA Imaging Service Offerings 2
(Date:8/1/2014)... Knowing what causes them at the molecular level is ... have created the most detailed map to date of ... blinding diseases, such as age-related macular degeneration. The high-resolution ... which supplies blood and oxygen to the outer retina, ... abundance of proteins in different areas of the choroid, ...
(Date:8/1/2014)... the conductive tissue through which plants transport carbohydrates and ... are capped at one end by a sieve plate ... turn form a network throughout a plant,s body. ... play an important role in carbon sequestration, yet so ... says Professor Yk Helariutta from the Institute of Biotechnology, ...
(Date:8/1/2014)... most diverse families in the ocean today -- marine ... more than 400 million years ago in the Silurian ... its modern members. This Geology study by ... on 25 July 2014, tracks the remarkable evolutionary expansion ... is origin, the Lucinidae family remained at very low ...
Breaking Biology News(10 mins):A map for eye disease 2Developmental regulation of important plant phloem components discovered 2Symbiotic survival 2Symbiotic survival 3Symbiotic survival 4Symbiotic survival 5Symbiotic survival 6Symbiotic survival 7Symbiotic survival 8Symbiotic survival 9Symbiotic survival 10Symbiotic survival 11Symbiotic survival 12Symbiotic survival 13Symbiotic survival 14
... Since its discovery in the 18th century, cocaine has ... reward centres in low doses, cocaine is extremely addictive ... potent compound did not evolve to ensnare humans in ... cocaine is a powerful insect neurotoxin, protecting coca bushes ...
... WA This Christmas season, think twice about spending ... tree. The good, old-fashioned methodkeeping your tree in a ... keep your tree green and healthy. Researchers have determined ... trees; in fact, in several cases the chemical retardants ...
... LANSING, Mich. Diversity is valuable socially, economically and ... has found that growing more corn to produce ethanol ... of beneficial insects to control pests, a loss valued ... states studied (Michigan, Iowa, Minnesota and Wisconsin). "Corn ...
Cached Biology News:Honeybees succumb to cocaine's allure 2Flame retardants prove ineffective on fresh-cut Christmas trees 2Diverse landscapes are better: Policymakers urged to think broadly about biofuel crops 2
... Dako Target Retrieval Solution, pH 9 ... Tris/EDTA buffer, pH 9, intended for heat-induced ... It is well-suited for use on formalin-fixed, ... Compared with 0.01 mol/L citrate buffer, pH ...
... White to off-white solid. Increases the expression of ... Soluble in H 2 O. Unstable in ... RTECS EK7713840, CAS 3211-76-5, M.W. 196.1. References: ... L., and Junod, A.F. 1995. Biochem. J. ...
... antifade reagent is used to ... standard fluorescence microscopy. The unique ... a wide variety of fixed ... fluorescein, rhodamine, sulforhodamine 101, coumarin, ...
...
Biology Products: